Table 3. Response to chemotherapy and serum YKL-40 levels.
Clinical response | All patients | YKL-40 (high) (%) | YKL-40 (low) (%) | p-value |
CR | 32 | 14 (43.8) | 18 (56.2) | |
PR | 33 | 24 (72.7) | 9 (27.3) | |
SD | 35 | 28 (80.0) | 7 (20.0) | |
PD | 20 | 15 (75.0) | 5 (25.0) | |
Response (CR+PR) | 65 | 38 (58.5) | 27 (41.5) | 0.031* |
Non-response (SD+PD) | 55 | 43 (78.2) | 12 (21.8) |
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.
*Significant difference.